Type 2 diabetes genetic risk scores are associated with increased type 2 diabetes risk among African Americans by cardiometabolic status

Clinical Medicine Insights: Endocrinology and Diabetes

Volumn 11, Issue , 2018, Pages

  Layton, Jill ^a   Li, Xiaochen ^a   Shen, Changyu ^a   de Groot, Mary ^a   Lange, Leslie ^b   Correa, Adolfo ^c   Wessel, Jennifer ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

African American health; Genetic epidemiology; Genetic risk factors; Risk prediction; Type 2 diabetes

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CARDIOMETABOLIC RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENETIC RISK SCORE; GENETIC VARIABILITY; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; PROSPECTIVE STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 85041428675     PISSN: None     EISSN: 11795514     Source Type: Journal    
DOI: 10.1177/1179551417748942     Document Type: Article

References (42)

1. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010; 8: 29.
2. Chow EA, Foster H, Gonzalez V, McIver L. The disparate impact of diabetes on racial/ethnic minority populations. Clin Diabetes. 2012; 30: 130-133.
3. Cheng CY, Reich D, Haiman CA, et al. African ancestry and its correlation to type 2 diabetes in African Americans: a genetic admixture analysis in three U.S. population cohorts. PLoS ONE. 2012; 7: e32840.
4. Meigs JB, Shrader P, Sullivan LM, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008; 359: 2208-2219.
5. Lyssenko V, Jonsson A, Almgren P, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008; 359: 2220-2232.
6. Scott RA, Lagou V, Welch RP, et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012; 44: 991-1005.
7. Vassy JL, Hivert M-F, Porneala B, et al. Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes. 2014; 63: 2172-2182.
8. Vassy JL, Durant NH, Kabagambe EK. A genotype risk score predicts type 2 diabetes from young adulthood: the CARDIA study. Diabetologia. 2012; 55: 2604-2612.
9. Cooke JN, Ng MC, Palmer ND, et al. Genetic risk assessment of type 2 diabetes-associated polymorphisms in African Americans. Diabetes Care. 2012; 35: 287-292.
10. Tam CH, Ho JS, Wang Y, et al. Use of net reclassification improvement (NRI) method confirms the utility of combined genetic risk score to predict type 2 diabetes. PLoS ONE. 2013; 8: e83093.
11. Klimentidis YC, Wineinger NE, Vazquez AI, de Los Campos G. Multiple metabolic genetic risk scores and type 2 diabetes risk in three racial/ethnic groups. J Clin Endocrinol Metab. 2014; 99: E1814-E1818.
12. Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012; 44: 981-990.
13. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010; 42: 105-116.
14. Manning AK, Hivert M-F, Scott RA, et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet. 2012; 44: 659-669.
15. Cornelis MC, Qi L, Zhang C, et al. Joint effects of common genetic variants on the risk for type 2 diabetes in U.S. men and women of European ancestry. Ann Intern Med. 2009; 150: 541-550.
16. Waters KM, Stram DO, Hassanein MT, et al. Consistent association of type 2 diabetes risk variants found in Europeans in diverse racial and ethnic groups. PLoS Genet. 2010; 6: e1001078.
17. Lango H, Palmer CN, Morris AD, et al. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes. 2008; 57: 3129-3135.
18. van Hoek M, Dehghan A, Witteman JC, et al. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes. 2008; 57: 3122-3128.
19. Weedon MN, McCarthy MI, Hitman G, et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med. 2006; 3: e374.
20. Hivert M-F, Jablonski KA, Perreault L, et al. Updated genetic score based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the Diabetes Prevention Program. Diabetes. 2011; 60: 1340-1348.
21. Vaxillaire M, Yengo L, Lobbens S, et al. Type 2 diabetes-related genetic risk scores associated with variations in fasting plasma glucose and development of impaired glucose homeostasis in the prospective DESIR study. Diabetologia. 2014; 57: 1601-1610.
22. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia. 2003; 46: 3-19.
23. Haffner SM, D’Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes. 1996; 45: 742-748.
24. Fesinmeyer MD, Meigs JB, North KE, et al. Genetic variants associated with fasting glucose and insulin concentrations in an ethnically diverse population: results from the Population Architecture using Genomics and Epidemiology (PAGE) study. BMC Med Genet. 2013; 14: 98.
25. McCormick S, Grant SF. Genetics of obesity and type 2 diabetes in African Americans. J Obes. 2013; 396416. doi: 10.1155/2013/396416.
26. Wyatt SB, Diekelmann N, Henderson F, et al. A community-driven model of research participation: the Jackson Heart Study Participant Recruitment and Retention Study. Ethn Dis. 2003; 13: 438-455.
27. Bild DE, Bluemke DA, Burke GL, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002; 156: 871-881.
28. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989; 129: 687-702.
29. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988; 41: 1105-1116.
30. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. https://www.idf.org/our-activities/advocacy-awareness/resources-and-tools/60:idfconsensus-worldwide-definitionof-the-metabolicsyndrome.html (accessed 13 December 2017).
31. Tang H, Peng J, Wang P, Risch NJ. Estimation of individual admixture: analytical and study design considerations. Genet Epidemiol. 2005; 28: 289-301.
32. Kosoy R, Nassir R, Tian C, et al. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat. 2009; 30: 69-78.
33. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. Berlin, Germany: Springer; 2000: 127-142.
34. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000; 56: 337-344.
35. Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med. 2008; 27: 157-172.
36. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2013. http://www.R-project.org/.
37. Poitout V, Amyot J, Semache M, et al. Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta. 2010; 1801: 289-298.
38. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346: 393-403.
39. Grant RW, O’Brien KE, Waxler JL, et al. Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial. Diabetes Care. 2013; 36: 13-19.
40. Middleton KR, Anton SD, Perri MG. Long-term adherence to health behavior change. Am J Lifestyle Med. 2013; 7: 395-404.
41. Pencina MJ, D’Agostino RB, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study. Circulation. 2009; 119: 3078-3084.
42. Schneider ALC, Pankow JS, Heiss G, Selvin E. Validity and reliability of selfreported diabetes in the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2012; 176: 738-743.